Stay updated on Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.

Latest updates to the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov record for the ECHO-206 study is displayed, including its terminated status and details about the trial design, treatment groups, eligibility, locations, and outcome measures.SummaryDifference63%

- Check17 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0; the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide banner announces an NIH terminology transition, noting that NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check38 days agoChange DetectedThe revision label in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the full study record content; the detailed study documents and related sections are no longer visible.SummaryDifference20%

Stay in the know with updates to Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.